Biotech Co. Gets OK For $16M Sale Of Monkey Cell Royalties
Biotechnology company Alachua Government Services received approval on Monday from a Delaware bankruptcy judge for a $16 million sale to healthcare investment firm OrbiMed Advisors LLC of the royalty rights to a...To view the full article, register now.
Already a subscriber? Click here to view full article